Welcome to RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers (RhAPP). In this episode, Amanda Mixon, PA-C, President of RhAPP, is joined by Kyle George, PA-C, to explore the world of biosimilars and how APPs can confidently educate patients about these treatments.
As biosimilars gain traction in rheumatology, understanding their role in clinical practice is essential. This discussion breaks down what biosimilars are, how they compare to reference biologics in terms of safety and efficacy, and addresses common misconceptions patients may have when switching to a biosimilar. The conversation also touches on the growing influence of insurance mandates on biosimilar adoption and how APPs can navigate these changes while advocating for patient-centered care.
With insurance providers increasingly driving the shift toward biosimilars, APPs are at the forefront of patient education. This episode equips clinicians with practical strategies, real-world analogies, and evidence-based insights to enhance patient confidence in biosimilar therapy.
Stay connected by subscribing to RhAPPcast on your favorite podcast platform for more in-depth discussions on biosimilars and other critical rheumatology topics.
Want to dive deeper? Explore more on the RhAPP website, the Content Rheum hub, or the RhAPP ACE App.
